Gene Query: MIS12

Dataset Description Geneva Score
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 65.58
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 65.45
Gene expression analysis of dengue-infected cells 42.27
Gene expression in PANC1 cells treated with Rakicidin 27.41
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 22.45
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 22.25
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 21.6
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 18.2
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 17.42
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 14.4
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 13.67
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 12.81
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 12.37
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 12.07
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 11.21
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 11.21
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 11.14
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 11.14
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 11.09
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 11.0
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 10.69
ETV7 and interferon response 10.69
Targeting MTHFD2 in Acute Myeloid Leukemia 10.63
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 10.14
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 9.72
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 9.72
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 9.56
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 9.46
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 9.42
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 9.26
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 9.26
U1 snRNP telescripting regulates size-function stratified human genome 9.23
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 9.08
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 8.95
MYCL and EP400 are required for Max and MCPyV mediated gene activation 8.94
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 8.89
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 8.8
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 8.76
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 8.71
AR-independent prostate cancer is sustained through FGF signaling 8.65
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 8.56
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 8.2
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 8.19
Transcriptome analysis in Neobractatin treated cells 8.02
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 7.62
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 7.32
Mapping interactions for the TNIP2 hub protein 7.17
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 7.11
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 7.11
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 7.11
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 6.89
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 6.81
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 6.76
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 6.73
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 6.73
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 6.69
Cell responses to dysregulated VZV-induced cell-cell fusion 6.5
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 6.37
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 6.35
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 6.35
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 6.34
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 6.17
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 6.05
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 6.05
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 6.02
Identification of global XBP1s target gene expression in human prostate cancer cells 5.97
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 5.96
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 5.96
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 5.88
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 5.74
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 5.7
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 5.6
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 5.6
DRB/GRO-Seq -/+ UV 5.54
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 5.53
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 5.52
IDH3a KO RNA-seq 5.5
Genome-wide analysis of Dengue virus 2 infected cells 5.49
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 5.45
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 5.4
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 5.4
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 5.4
Determining mRNA half-lives on a transcriptome-wide scale 5.4
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 5.35
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 5.29
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 5.26
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 5.23
The role of FAM46C in myeloma cells [sequencing] 5.22
The role of FAM46C in myeloma cells 5.22
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 5.2
IRF2 is a master regulator of human keratinocyte stem cell fate 5.2
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 5.2
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 5.12
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 5.12
Seletive inhibition of CDK9 in DLBCL cell lines 5.09
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 5.05
Tracking of dCas9-methyltransferase footprints 5.01
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 4.92
Noncoding regions are the main source of targetable tumor-specific antigens 4.92
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 4.9
Trans-differentiation of human adult peripheral blood T cells into neurons 4.87
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 4.84
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 4.83
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 4.81
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 4.79
Effect of drugs on transcriptomic profiles 4.78
Global Mapping of Human RNA-RNA Interactions 4.75
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.68
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 4.68
Integrin signaling regulates YAP/TAZ to control skin homeostasis 4.64
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 4.62
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 4.61
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 4.61
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 4.59
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 4.58
SLIGRL-induced gene expression changes in NHEK cells 4.56
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 4.54
SETBP1-WT and SETBP1-G870S epigenetic landscapes 4.54
The Human Testis Cell Atlas via Single-cell RNA-seq 4.51
The evolution of N6-methyladenosine in primates 4.47
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.46
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 4.43
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 4.37
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.34
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 4.33
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 4.33
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 4.33
IRF1 regulates IFN dependent and independent gene expression 4.3
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 4.29
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 4.28
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 4.25
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 4.25
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 4.24
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 4.23
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.22
FBXW7 modulates stress response by post-translational modification of HSF1 4.22
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 4.16
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 4.16
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 4.15
Gene expression changes associated with resistance to tagraxofusp (SL-401) 4.14
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 3.97
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 3.92
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 3.9
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 3.9
Ribosomal footprinting of CN34-Parental and CN34-LM1a 3.87
Proliferation-correlated expression 3.86
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 3.85
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 3.85
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.85
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 3.85
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 3.83
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 3.8
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 3.8
RNAseq of HEK293 cells after Chtop knockdown 3.73
Co-transcriptional loading of RNA export factors shapes the human transcriptome 3.73
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 3.71
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 3.7
R430: A potent inbibitor of DNA and RNA viruses 3.66
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 3.64
Gene expression signatures of innate lymphoid cells from human blood 3.61
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 3.61
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.61
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 3.6
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 3.6
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 3.59
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 3.59
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 3.57
O-glcnAc reprograms cellular energetics 3.56
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 3.55
Genes significantly down or Up-regulated upon RNF219 knockdown 3.55
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 3.5
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 3.5
Genome wide expression change by RNF168 knocking down in NEC cells 3.45
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.4
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 3.4
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 3.39
mRNA recovered upon RNF219 IP. [RNA-IP] 3.39
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 3.39
Ribosomal footprinting of MDA-Parental and MDA-LM2 3.38
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.36
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 3.36
HEK293 TFAM Knockout Expression Study 3.35
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.35
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.33
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.33
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 3.32
MOF acetyl transferase regulates transcription and respiration in mitochondria 3.31
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 3.3
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 3.3
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 3.3
Total RNA-seq in ALL-SIL upon TLX1 knockdown 3.29
Transcriptome of activated human and mouse MAIT cells 3.28
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 3.28
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 3.27
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 3.24
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.23
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 3.22
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 3.22
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 3.21
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.21
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 3.19
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 3.19
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 3.13
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.12
Global gene expression profile of dasatinib-resistant RCH-ACV cells 3.11
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.11
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 3.11
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 3.11
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 3.08
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 3.05
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 3.05
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 3.02
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 3.01
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 3.0
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 3.0
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.99
Global analysis of alternative splicing regulated by RBM10 2.99
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 2.98
Genome wide miR-191 target profile determined by RIP and gene expression profiling 2.98
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 2.97
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 2.97
Regulation of hypoxia-inducible factor activity by ZMYND8 2.96
The Genetic Landscape of Diamond-Blackfan Anemia 2.96
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 2.96
Hijacking of stress response machinery by oncogenes in acute leukaemia 2.96
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 2.96
Generation of KRAS signatures using immortalized isogenic lung cells. 2.93
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.93
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.93
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 2.93
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 2.92
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 2.91
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.91
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.91
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 2.91
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 2.88
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 2.86
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 2.86
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.85
Identification of Nrf2 regulated genes by RNA sequencing 2.8
Nrf2 regulated genes in A549 cells 2.8
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 2.79
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 2.79
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 2.78
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 2.78
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 2.77
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.76
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 2.75
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 2.75
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 2.72
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.71
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 2.7
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 2.7
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 2.69
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 2.67
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 2.67
Profiling of escape kinetics of viruses subjected to RNAi 2.65
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 2.63
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.6
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 2.6
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.59
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 2.56
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.56
Differential Protein Occupancy Profiling of the mRNA Transcriptome 2.56
Systematic discovery of endogenous human ribonucleoprotein complexes 2.53
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 2.51
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 2.5
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 2.49
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 2.49
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 2.49
m6A-dependent regulation of messenger RNA stability 2.47
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.45
Tracing Enhancer Networks using Epigenetic Traits (TENET) 2.43
Effect of PRDM11 depletion in U2932 cells 2.41
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.41
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.41
The MEF2B Regulatory Network - RNA-seq data 2.37
The MEF2B Regulatory Network 2.37
LIN28A Over-expression RNAseq 2.37
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 2.35
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 2.34
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 2.34
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 2.34
Effect of CHKA knockdown on C4-2 cell transcriptome 2.33
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 2.33
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 2.32
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 2.3
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 2.28
Gene expression profile of multiple myeloma cell lines treated with CB-5083 2.27
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 2.27
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 2.25
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 2.25
Disruption of GRIN2B impairs differentiation in human neurons 2.24
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.23
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 2.22
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.17
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.17
Effect of BB608 on Gene Expression in HNSCC Cell Line 2.17
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 2.14
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 2.13
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.13
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.12
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.09
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.09
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 2.03
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.03
Functional significance of the HIV-1 Tat signature amino acid residues 1.98
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 1.98
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 1.98
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 1.98
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 1.97
Gene expression analysis of the impact of TDP-43 knockout in human cells. 1.96
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 1.96
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.92
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.92
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.91
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 1.88
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 1.87
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 1.87
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 1.85
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.84
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.83
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.83
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.82
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.82
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 1.79
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.78
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.78
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.76
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.75
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 1.73
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.72
High-resolution comparative analysis of great ape genomes 1.7
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.7
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 1.7
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 1.69
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 1.67
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 1.67
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 1.64
Downregulation of DDX5/DDX17 and REST 1.62
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 1.62
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 1.62
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.61
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.6
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.59
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.59
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.56
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.56
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.56
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.55
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.55
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 1.52
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 1.51
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.49
NHLRC1 re-expression in cancer cells 1.48
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 1.45
The cytokine environment influence on human skin-derived T cells 1.43
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 1.41
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.41
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.38
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 1.37
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 1.34
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 1.32
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.32
hnRNP C is a key regulator of protein synthesis in mitosis 1.3
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 1.3
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.25
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.23
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.2
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.19
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 1.19
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.17
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 1.17
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.17
Gene expression profile in breast cancer cells 1.17
HBEC-shp53-PCHD7 1.16
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 1.16
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.15
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.14
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.13
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.11
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 1.1
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 1.06
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.06
RNA-seq analysis of differentiating human erythroblasts 1.04
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.02
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.01
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 1.01
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 1.0
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 1.0
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 1.0
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.99
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 0.98
EWSR1 influences alternative splicing through direct and indirect mechanisms 0.98
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 0.98
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 0.98
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.97
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 0.97
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.96
siRNA-mediated knockdown 0.93
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.91
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.91
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.9
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.9
RNA-Seq of PRMT1 overexpression ECA109 cells 0.9
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.87
Role of COP1 on MAP kinase transcriptional output in melanoma 0.85
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.85
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.84
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.83
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 0.82
Genome-wide analysis of the Integrator complex (HTS) 0.8
Genome-wide analysis of the Integrator complex 0.8
Human Treg NaCl stimulation 0.8
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 0.8
Gene expressions of H9s in different culture systems 0.79
MAIT cell RNA sequencing 0.78
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 0.75
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 0.75
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.73
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 0.71
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.69
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 0.67
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.67
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.67
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.65
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.65
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 0.64
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 0.64
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.61
Transcriptomic analysis of LSD1 0.61
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.6
Human Treg IFNg/IL-10 subpopulations 0.59
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.58
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.57
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.57
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.57
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.55
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.55
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.55
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 0.54
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 0.54
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.53
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 0.51
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 0.51
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 0.51
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.49
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.49
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 0.49
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 0.48
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.46
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.42
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.41
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.41
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 0.4
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.38
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.37
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 0.37
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.35
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.33
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.3
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.29
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.27
Ribosomal protein RPL26 is the principal target of UFMylation 0.27
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 0.25
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.25
Discovering human diabetes-risk gene function with genetics and physiological assays 0.2
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.19
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.19
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.19
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.19
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.18
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.18
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.17
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.17
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.17
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.17
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 0.16
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.16
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.15
The transcriptome and chromatin accessbility landscape of mammalian germline 0.14
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.14
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.13
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.13
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.1
Transcriptome-wide modulation of splicing by the exon junction complex 0.08
Modulation of nonsense-mediated decay by rapamycin 0.07
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.07
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.07
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.06
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.06
Dermal endothelial cells of type 2 diabetic patients 0.05
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.03
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.03
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.02
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.02
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.02
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.02
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.0
Role of FGFR1 in neuronal devlopment 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation